Copyright
©The Author(s) 2025.
World J Cardiol. Mar 26, 2025; 17(3): 102999
Published online Mar 26, 2025. doi: 10.4330/wjc.v17.i3.102999
Published online Mar 26, 2025. doi: 10.4330/wjc.v17.i3.102999
Table 1 Basic clinical data of the patients with cancer in the present study
| Characteristics | n | % |
| Male | 73 | 57.5 |
| Female | 54 | 42.5 |
| Age < 65 years | 48 | 37.8 |
| Age ≥ 65 years | 79 | 62.2 |
| Head and neck tumor | 37 | 29.1 |
| Thoracic tumor | 62 | 48.8 |
| Digestive system tumor | 16 | 12.6 |
| Others tumor | 12 | 9.5 |
| Stage I | 15 | 11.8 |
| Stage II | 27 | 21.3 |
| Stage III | 52 | 40.9 |
| Stage Ⅳ | 33 | 26.0 |
Table 2 Results of the heart rate variability for cancer patients
| Index | Reference group[7,8] | Cancer group | P value |
| Total | 127 | ||
| Time domain analysis, 24 hours | |||
| SDNN, ms | 141 ± 39 | 102.12 ± 23.48 | < 0.05 |
| SDANN, ms | 127 ± 35 | 95.3 ± 31.25 | < 0.05 |
| SDNNIDX, ms | 50 ± 13 | 38.3 ± 21.4 | < 0.05 |
| Triangle index | 37 ± 15 | 24.0 ± 5.12 | < 0.05 |
| pNN50, % | 7.95 ± 8.15 | 4.06 ± 0.59 | < 0.05 |
| Frequency domain analysis, 24 hours | < 0.05 | ||
| VLF, ms2 | 1124 ± 316 | 631.9 ± 275.3 | < 0.05 |
| LF, ms2 | 1170 ± 416 | 426 ± 153 | < 0.05 |
| LF/HF | 1.75 ± 0.67 | 1.29 ± 0.48 | < 0.05 |
Table 3 Association of clinical factors with heart rate variability
| Factor | SDNN, ms | pNN50, % | VLF, ms2 | LF/HF |
| Sex | P > 0.05 | P > 0.05 | P > 0.05 | P > 0.05 |
| Male | 104.67 ± 32.57 | 4.22 ± 0.75 | 657.6 ± 271.3 | 1.35 ± 0.49 |
| Female | 101.67 ± 35.35 | 4.12 ± 0.71 | 612.5 ± 281.3 | 1.23 ± 0.51 |
| Age, years | P < 0.05 | P < 0.05 | P < 0.05 | P < 0.05 |
| < 65 | 111.43 ± 32.51 | 4.58 ± 0.73 | 665.6 ± 289.1 | 1.39 ± 0.43 |
| ≥ 65 | 92.12 ± 31.31 | 3.38 ± 0.56 | 553.6 ± 252.1 | 1.12 ± 0.46 |
| Tumor location | P > 0.05 | P > 0.05 | P > 0.05 | P > 0.05 |
| Cardia | 104.28 ± 33.67 | 4.18 ± 0.65 | 633.8 ± 275.3 | 1.31 ± 0.42 |
| Body | 103.12 ± 33.7 | 4.15 ± 0.76 | 635.3 ± 276.2 | 1.35 ± 0.49 |
| Antrum | 102.34 ± 35.1 | 4.06 ± 0.62 | 611.6 ± 289.2 | 1.18 ± 0.51 |
| Diffuse | 103.36 ± 35.18 | 4.16 ± 0.78 | 631.8 ± 279.4 | 1.32 ± 0.48 |
| Clinical type | P < 0.05 | P < 0.05 | P < 0.05 | P < 0.05 |
| I | 111.96 ± 32.98 | 4.87 ± 0.32 | 698.3 ± 254.6 | 1.49 ± 0.52 |
| II | 99.86 ± 31.98 | 4.07 ± 0.62 | 658.3 ± 224.3 | 1.41 ± 0.35 |
| III | 87.95 ± 31.58 | 3.57 ± 1.22 | 572.1 ± 289.6 | 1.38 ± 0.39 |
| Ⅳ | 80.15 ± 29.68 | 3.27 ± 0.85 | 522.1 ± 259.4 | 1.15 ± 0.48 |
- Citation: Deng YZ, Song B. Connection between heart rate variability alterations and cancer in tumor patients. World J Cardiol 2025; 17(3): 102999
- URL: https://www.wjgnet.com/1949-8462/full/v17/i3/102999.htm
- DOI: https://dx.doi.org/10.4330/wjc.v17.i3.102999
